Rotork plc (LON:ROR)
London · Delayed Price · Currency is GBP · Price in GBX 347.00
+0.40 (0.12%)
Aug 13, 2025, 4:42 PM BST
CTI BioPharma Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 99.59 | 103.59 | 113.14 | 93.24 | 80.25 | 85.76 | Upgrade |
Depreciation & Amortization | 17.4 | 16.9 | 15.64 | 21.98 | 24.67 | 30.42 | Upgrade |
Other Amortization | 2.91 | 3.61 | 2.35 | 1.44 | 1.66 | 2.44 | Upgrade |
Loss (Gain) From Sale of Assets | 0.09 | -0.11 | -1.07 | -1.37 | -1.57 | 0.15 | Upgrade |
Asset Writedown & Restructuring Costs | 22.21 | 17.21 | 13.1 | 8.87 | 6.45 | 6.38 | Upgrade |
Stock-Based Compensation | 7.06 | 6.66 | 5.67 | 4.6 | 3.33 | 3.69 | Upgrade |
Other Operating Activities | 15.05 | 16.25 | 4.03 | 5.07 | 1.94 | 6.04 | Upgrade |
Change in Accounts Receivable | -17.96 | -1.06 | -10.49 | -32.59 | 5.94 | 14.67 | Upgrade |
Change in Inventory | 5.26 | -1.44 | 5.49 | -19.48 | -8.33 | 12.56 | Upgrade |
Change in Accounts Payable | 8.42 | 12.02 | 1.4 | -2.9 | 2.58 | -7.2 | Upgrade |
Change in Other Net Operating Assets | -24.85 | -24.85 | -24.37 | -19.35 | -31.48 | -27.46 | Upgrade |
Operating Cash Flow | 135.17 | 148.77 | 124.89 | 59.51 | 85.44 | 127.45 | Upgrade |
Operating Cash Flow Growth | -5.27% | 19.12% | 109.86% | -30.35% | -32.96% | -17.47% | Upgrade |
Capital Expenditures | -13.68 | -13.98 | -7.31 | -8.29 | -13.17 | -15.47 | Upgrade |
Sale of Property, Plant & Equipment | 2.12 | 0.22 | 1.88 | 4.63 | 3.81 | 0.27 | Upgrade |
Cash Acquisitions | -31.8 | - | -18.4 | - | - | - | Upgrade |
Divestitures | - | - | - | - | - | 3.81 | Upgrade |
Sale (Purchase) of Intangibles | -5.66 | -5.96 | -4.5 | -4.61 | -6.98 | -1.3 | Upgrade |
Other Investing Activities | 3.57 | 6.77 | 4.86 | 0.76 | 4.96 | -1.77 | Upgrade |
Investing Cash Flow | -45.45 | -12.95 | -23.46 | -7.51 | -11.38 | -14.45 | Upgrade |
Long-Term Debt Repaid | - | -4.22 | -3.7 | -4.66 | -4.97 | -5.24 | Upgrade |
Net Debt Issued (Repaid) | -12.52 | -4.22 | -3.7 | -4.66 | -4.97 | -5.24 | Upgrade |
Issuance of Common Stock | 0.74 | 0.84 | 1.05 | 1.13 | 2.01 | 2.31 | Upgrade |
Repurchase of Common Stock | -63.27 | -60.67 | -2.44 | -3.48 | -58.13 | -3.65 | Upgrade |
Common Dividends Paid | -65.47 | -63.27 | -58.82 | -55.38 | -75.52 | -33.93 | Upgrade |
Other Financing Activities | -3.06 | -2.16 | -0.94 | 0.6 | -0.88 | -0.95 | Upgrade |
Financing Cash Flow | -143.57 | -129.47 | -64.85 | -61.79 | -137.49 | -41.45 | Upgrade |
Foreign Exchange Rate Adjustments | -10.94 | -2.74 | -4.98 | 1.08 | -0.3 | -1.95 | Upgrade |
Net Cash Flow | -64.79 | 3.61 | 31.6 | -8.7 | -63.73 | 69.59 | Upgrade |
Free Cash Flow | 121.49 | 134.79 | 117.59 | 51.22 | 72.27 | 111.98 | Upgrade |
Free Cash Flow Growth | -8.67% | 14.63% | 129.57% | -29.13% | -35.46% | -18.34% | Upgrade |
Free Cash Flow Margin | 15.98% | 17.87% | 16.35% | 7.98% | 12.70% | 18.52% | Upgrade |
Free Cash Flow Per Share | 0.14 | 0.16 | 0.14 | 0.06 | 0.08 | 0.13 | Upgrade |
Cash Interest Paid | 1.98 | 1.88 | 0.94 | 0.82 | 0.88 | 0.95 | Upgrade |
Cash Income Tax Paid | 40.26 | 38.76 | 32.83 | 30.22 | 32.02 | 30.78 | Upgrade |
Levered Free Cash Flow | 107.43 | 119.72 | 135.61 | 45.98 | 66.74 | 114.69 | Upgrade |
Unlevered Free Cash Flow | 108.77 | 121.12 | 136.42 | 46.7 | 67.51 | 115.55 | Upgrade |
Change in Working Capital | -29.14 | -15.34 | -27.97 | -74.32 | -31.28 | -7.43 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.